Davide Buffoni has been appointed as the new General Manager of TEOXANE Iberia, thus consolidating a stage of evolution and sustained growth for the organization in Spain and Portugal. This appointment, effective from July 2025, recognizes Davide's commitment, strategic vision, and achievements since joining the company in October 2024 as Commercial Director.
Since joining TEOXANE Iberia, Davide has played a key role in strengthening commercial operations, driving growth, and consolidating its position as leaders in the aesthetic medicine sector. His leadership has been fundamental in laying the foundations for this new, more ambitious stage, focused on the sustainable development of our business.
With more than 25 years of international experience in the pharmaceutical and consumer sector, Davide has held senior positions in companies such as Allergan, as well as in Dompé laboratories, Horus Pharma, and Nicox, where he served as General Manager. His career is complemented by previous experiences in global companies such as Pfizer, Danone, and Procter & Gamble, which have allowed him to acquire a comprehensive strategic vision and an outstanding ability to lead high-performance teams.
Davide is a management, engineering, and economics engineer from the Polytechnic University of Turin, and holds a master's degree in digital marketing from the CEU University of Valencia. In addition, he has valuable experience in the creation and management of private medicine clinics, which gives him a unique and close perspective of the market in which we operate.
Under his leadership, TEOXANE Iberia will continue to grow with solidity, innovation, and excellence, reaffirming our commitment to cutting-edge aesthetic medicine and the well-being of our patients and professionals.